Lung cancer trial combines immunotherapy, chemo, and bronchoscopy to boost effectiveness
NCT ID NCT04702009
First seen May 06, 2026 · Last updated May 06, 2026
Summary
This study tested whether adding a bronchoscopy-guided treatment to standard immunotherapy and chemotherapy could help people with advanced central non-small cell lung cancer. The trial involved 33 participants and measured how long the cancer stayed under control. The goal is to improve outcomes for patients whose cancer cannot be surgically removed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai pulmonary hospital, Tongji University
Shanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.